logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
04/08/2025
Anfinn's pre-market increase is close to 4%. Anfinn plans to acquire the broadband business unit of network infrastructure company CommScope, and expects this acquisition to increase Anfinn's earnings per share.
Latest
3 m ago
The rise in U.S. Treasury bonds has paused, as $125 billion in new bonds will be issued this week.
4 m ago
Shenzhen Qianhai strives to create a "preferred destination" for foreign investment. In the first half of the year, actual use of foreign investment increased by 15.9% year-on-year.
4 m ago
In the first half of this year, the actual use of foreign capital in Qianhai Cooperation Zone reached 12.326 billion yuan, a year-on-year increase of 15.9%, accounting for 59.0% of Shenzhen's total. The actual use of foreign capital in Qianhai and Shekou Free Trade Zone reached 10.702 billion yuan, a year-on-year increase of 40.5%. Under a higher level of opening up, Qianhai has formed a stronger attraction for foreign capital. Recently, with the opening of Google's cross-border e-commerce acceleration center in Qianhai, Qianhai has gathered 9 cross-border e-commerce platforms, around 10,000 cross-border e-commerce sellers, and about 100 service providers. International e-commerce giants are rushing to settle in, and the scale of QFLP (Qualified Foreign Limited Partner) funds continues to expand. As one of the most open regions in the country, Qianhai Cooperation Zone is increasingly becoming a strategic hub for foreign investment to deeply cultivate China and connect to the global market. (Shenzhen Special Zone News)
4 m ago
Hong Kong Observatory: Whether to issue a red rainstorm warning signal depends on the development of thunderstorms.
4 m ago
Biotechnology company Editas Medicine's stock soared over 23% after its second quarter revenue reached $1.11 billion, an 11% year-on-year increase. Its non-GAAP earnings per share rose by 17% to $3.30.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.